1848 Phase II clinical trial of metronomic oral capecitabine therapy combined with aromatase inhibitors in postmenopausal metastatic and recurrent breast cancer resistant to first-line aromatase inhibitors

2015 ◽  
Vol 51 ◽  
pp. S281 ◽  
Author(s):  
L. Jian-wei ◽  
J. Xiao-qing ◽  
L. Li ◽  
W. Yu-jie ◽  
S. Zhi-min ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Phase Ii ◽  
Aromatase Inhibitors ◽  
Recurrent Breast Cancer ◽  
Phase Ii Clinical Trial ◽  
First Line ◽  
Oral Capecitabine ◽  
Recurrent Breast

A Multicenter Phase II Study of Docetaxel 60 mg/m2 as First-Line Chemotherapy in Patients with Advanced or Recurrent Breast Cancer

Breast Cancer ◽  
2004 ◽  
Vol 11 (4) ◽  
pp. 374-379 ◽  
Author(s):  
Takashi Ishikawa ◽  
Satoru Shimizu ◽  
Masaaki Inaba ◽  
Taro Asaga ◽  
Kiyohumi Katayama ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Breast Cancer ◽  
First Line ◽  
Multicenter Phase ◽  
Recurrent Breast ◽  
Line Chemotherapy

A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

2007 ◽  
Vol 25 (6) ◽  
pp. 545-551 ◽  
Author(s):  
Sheri K. Dennison ◽  
Samuel A. Jacobs ◽  
John W. Wilson ◽  
Janell Seeger ◽  
Terrence P. Cescon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Advanced Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer

2018 ◽  
Vol 38 (7) ◽  
pp. 4073-4081 ◽  
Author(s):  
KOICHI SAKAGUCHI ◽  
KATSUHIKO NAKATSUKASA ◽  
HIROSHI KOYAMA ◽  
MAKOTO KATO ◽  
AKIRA SAKUYAMA ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
First Line ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen

2014 ◽  
Vol 73 (4) ◽  
pp. 857-867 ◽  
Author(s):  
Daniel E. Castellano ◽  
Joaquim Bellmunt ◽  
José Pablo Maroto ◽  
Albert Font-Pous ◽  
Rafael Morales-Barrera ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Urothelial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document